OSCR

Compensatory Intercellular Mitochondrial Transfer Improves Bioenergetics in P301L Tau-Affected Neuronal Cells.

Overview

Authors: Aurélien Riou1,2, Aline Broeglin1,2, Andreas Papassotiropoulos2, Anne Eckert3, Amandine Grimm1,2,3
  1. Cell Biology & Energy Metabolism, University Psychiatric Clinics (UPK) Basel, University of Basel, 4002 Basel, Switzerland; (A.R.); (A.B.)
  2. Research Cluster Molecular and Cognitive Neurosciences, Department of Biomedicine, University of Basel, 4055 Basel, Switzerland
  3. Neurobiology Laboratory for Brain Aging and Mental Health, University Psychiatric Clinics (UPK) Basel, University of Basel, 4002 Basel, Switzerland
Institutions: University of Basel (Switzerland); Universitäre Psychiatrische Kliniken Basel (Switzerland)
Journal: Cells, volume 15, issue 12, article 1101
Dates: received 30 April 2026; accepted 12 June 2026; published online 17 June 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/cells15121101 · PMID 42346128 · PMCID PMC13297239 · OpenAlex W7165034315
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), other condition (population), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Spectral & time-frequency, Statistics, Connectivity, Evoked potentials
Keywords: intercellular mitochondrial transfer, mitochondria, tauopathies, astrocytes, neurons
MeSH: Energy Metabolism*, Mitochondria*, Neurons*, tau Proteins*, Tauopathies*, Astrocytes, Cell Line, Tumor, Coculture Techniques, Humans, Induced Pluripotent Stem Cells (* major topic)
Topic: Mitochondrial Function and Pathology (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Novartis Forschungsstiftung FreeNovation; OPO Foundation; Stiftung Synapsis - Alzheimer Forschung Schweiz AFS (2022-PI05); Bürgenstock Foundation
Citations: not cited yet (Europe PMC); 42 references in the paper

Abstract

Highlights: What are the main findings? Intercellular mitochondrial transfer from astrocytes to neurons is significantly increased in the presence of P301L mutant tau. Contact-dependent transfer appears to be the dominant pathway of mitochondrial transfer, with an increased number of tunneling nanotubes between astrocytes and P301L-expressing neuronal cells. Abnormal tau protein does not significantly alter the intracellular fate of transferred mitochondria. Transferred astrocytic mitochondria remain functional and improve cellular bioenergetics in recipient cells.

What are the implications of the main findings? Our findings identified a novel protective mechanism supporting neuronal bioenergetics in tauopathies. Mitochondrial transfer may represent an attractive therapeutic strategy to compensate for energy deficits in neurodegeneration.

Abstract: Tauopathies are a group of neurodegenerative diseases characterized by the accumulation of abnormal tau protein, leading to mitochondrial dysfunction. Because of neurons’ high energy demands, such impairments significantly contribute to neuronal vulnerability. Recent evidence indicates that mitochondria can be transferred between cells to support energy-deficient cells through intercellular mitochondrial transfer (IMT). Given the impact of pathological tau on mitochondrial transport and cytoskeletal dynamics, we hypothesized that IMT is altered in tauopathies. We investigated IMT from astrocytes to neurons, as well as the influence of abnormal tau protein on this process, using co-cultures of SH-SY5Y cells (neuronal model) and A172 cells (astrocytic model). Key data were then confirmed in human iPSC-derived neurons and astrocytes. We show that IMT is enhanced in the presence of abnormal tau and occurs predominantly through contact-dependent mechanisms. Transferred mitochondria were either integrated into the host mitochondrial network, degraded in lysosomes, or remained isolated in the recipient cells’ cytosol. This transfer improved cellular respiration and was associated with increased bioenergetics in pathological cells. Together, our results highlight IMT as a link between tau pathology and neuronal metabolic adaptation, suggesting that this process reflects an endogenous metabolic adaptation holding therapeutic potential to mitigate energy deficits in neurodegenerative diseases.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The data presented in this study are available on: https://osf.io/zfdga/overview?view_only=91980eea9f0142f291ad6550f670fe5c (accessed on 30 April 2026).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 5 keywords, 10 MeSH terms, 4 funders, 42 references.

Cite

This paper

Riou, A., Broeglin, A., Papassotiropoulos, A., Eckert, A., & Grimm, A. (2026). Compensatory Intercellular Mitochondrial Transfer Improves Bioenergetics in P301L Tau-Affected Neuronal Cells. Cells, 15(12), 1101. https://doi.org/10.3390/cells15121101

BibTeX

@article{riou2026compensatory,
author = {Riou, Aurélien and Broeglin, Aline and Papassotiropoulos, Andreas and Eckert, Anne and Grimm, Amandine},
title = {{Compensatory Intercellular Mitochondrial Transfer Improves Bioenergetics in P301L Tau-Affected Neuronal Cells}},
journal = {Cells},
year = {2026},
month = jun,
volume = {15},
number = {12},
pages = {1101},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2073-4409},
doi = {10.3390/cells15121101},
url = {https://doi.org/10.3390/cells15121101},
pmid = {42346128},
pmcid = {PMC13297239}
}

RIS

TY - JOUR
AU - Riou, Aurélien
AU - Broeglin, Aline
AU - Papassotiropoulos, Andreas
AU - Eckert, Anne
AU - Grimm, Amandine
TI - Compensatory Intercellular Mitochondrial Transfer Improves Bioenergetics in P301L Tau-Affected Neuronal Cells
T2 - Cells
J2 - Cells
PY - 2026
DA - 2026/06/17
VL - 15
IS - 12
SP - 1101
SN - 2073-4409
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/cells15121101
UR - https://doi.org/10.3390/cells15121101
LA - en
ER -

CSL-JSON

{
"id": "10.3390/cells15121101",
"type": "article-journal",
"title": "Compensatory Intercellular Mitochondrial Transfer Improves Bioenergetics in P301L Tau-Affected Neuronal Cells",
"container-title": "Cells",
"author": [
{
"family": "Riou",
"given": "Aurélien"
},
{
"family": "Broeglin",
"given": "Aline"
},
{
"family": "Papassotiropoulos",
"given": "Andreas"
},
{
"family": "Eckert",
"given": "Anne"
},
{
"family": "Grimm",
"given": "Amandine"
}
],
"container-title-short": "Cells",
"volume": "15",
"issue": "12",
"page": "1101",
"DOI": "10.3390/cells15121101",
"PMID": "42346128",
"PMCID": "PMC13297239",
"ISSN": "2073-4409",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/cells15121101",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
17
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.isci.2026.117187 [code]
Functional and structural characterization of dendritic spine pathology in a mouse model of tauopathy.
Journal: iScience
In common: Alzheimer's / dementia, 3 references
[2] doi:10.1162/imag.a.1213
Neural correlates of emotional memory enhancement: The role of valence and arousal.
Journal: Imaging neuroscience (Cambridge, Mass.)
In common: author Andreas Papassotiropoulos
[3] doi:10.1002/alz.71680
A combined artificial intelligence-wet lab approach identifies a pivotal role of the NAD<sup>+</sup>-mitophagy axis on aging and neurodegeneration.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: Alzheimer's / dementia, other condition, cellular / molecular, 2 references
[4] doi:10.3390/cimb48070691
Astrocyte Subtype-Specific Expression of the Sodium-Coupled Citrate Transporter <i>SLC13A5</i> and Citrate Metabolism Genes Across Alzheimer's Disease Pseudoprogression: A Single-Nucleus RNA Sequencing Analysis of the Human Middle Temporal Gyrus.
Journal: Current issues in molecular biology
In common: Alzheimer's / dementia, cellular / molecular, 2 references
[5] doi:10.1126/sciadv.adt2527
NPAS3-regulated astrocyte mitochondrial bioenergetics is required for cognition.
Journal: Science advances
In common: cellular / molecular, 2 references
[6] doi:10.1016/j.isci.2026.116092
Sigma-1 receptor promotes glycolysis in neuronal systems by suppressing GRIM19.
Journal: iScience
In common: cellular / molecular, 2 references
[7] doi:10.1002/advs.76205 [code]
CHCHD10 Mitigates Alzheimer's Disease-Related Phenotypes in Association With Epigenetic Remodeling in Directly Reprogrammed Neurons.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: Alzheimer's / dementia, cellular / molecular, 1 reference
[8] doi:10.1080/19491034.2026.2697135
Elevation of the mechanically-sensitive e protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons.
Journal: Nucleus (Austin, Tex.)
In common: Alzheimer's / dementia, cellular / molecular, 1 reference
[9] doi:10.1038/s41467-026-76837-1 [code]
Drug screen and machine learning predict neuroprotective agents in a preclinical human model of childhood dementia.
Journal: Nature communications
In common: Alzheimer's / dementia, other condition, 1 reference
[10] doi:10.1186/s40035-026-00565-1
Plant-derived mitochondria mitigate aging-related neurodegeneration by reprogramming microglial mitochondrial energy metabolism.
Journal: Translational neurodegeneration
In common: other condition, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.